Lucira Health Reports Pilot Study Interim Results for Chlamy

Study Reveals Lucira’s Testing Assays Offer a 98% Accuracy Rate in Detecting Both Sexually Transmitted InfectionsEMERYVILLE, Calif., Sept. 29, 2022 -- Lucira Health, Inc. , a medical... | September 29, 2022

Related Keywords

United States , Fiji , Russia , Ukraine , Debkishore Mitra , Greg Chodaczek , Mike Stommel , Founder At Lucira Health , Lucira Health , Lucira Health Or , National Institutes Of Health , Ministry Of Health , Services Health Centers , Us Preventative Services Task , Nasdaq , Lucira Health Inc , Exchange Commission , Study Reveals Lucira , Testing Assays Offer , Accuracy Rate , Detecting Both Sexually Transmitted , National Institutes , Deborah Dean , Lucira Chlamydia , Cepheid Xpert , Medical Services Health Centers , Chief Technology Officer , Services Task Force , Sexually Transmitted Infections , Private Securities Litigation Reform Act , Annual Report , Nc Stock Exchange , News , Information , Press Release , Study , Eveals , Testing , Essays , Offer , Accuracy , Gate , N , Detecting , Moth , Sexually , Ransmitted , 022 , Ucira Lhdx Us54948u1051 ,